TICKERNOMICS Sign up
Last Update: 2023-12-23 06:02:39
PhenomeX Inc. ( CELL )
1.00USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-66.62%
CELL
SPY
30.72%
-99.04%
CELL
SPY
112.82%
CELL
0.00%
SPY
201.04%
CELL
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
98.92
240.91
0.20
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.79
1.38
0.89
-61.74
0.00
-2.61
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-210.19
42.97
-143.25
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-38.67
-51.25
0.00
Other Earnings and Cash Flow Stats:
PhenomeX Inc. ( CELL ) Net Income TTM ($MM) is -126.86
PhenomeX Inc. ( CELL ) Operating Income TTM ($MM) is -102.82
PhenomeX Inc. ( CELL ) Owners' Earnings Annual ($MM) is 0.00
PhenomeX Inc. ( CELL ) Current Price to Owners' Earnings ratio is 0.00
PhenomeX Inc. ( CELL ) EBITDA TTM ($MM) is -88.05
PhenomeX Inc. ( CELL ) EBITDA Margin is -143.25%
Capital Allocation:
PhenomeX Inc. ( CELL ) has paid 0.00 dividends per share and bought back -30.538132 million shares in the past 12 months
PhenomeX Inc. ( CELL ) has increased its debt by 141.631 million USD in the last 12 months
Capital Structure:
PhenomeX Inc. ( CELL ) Interest-bearing Debt ($MM) as of last quarter is 188
PhenomeX Inc. ( CELL ) Annual Working Capital Investments ($MM) are 46
PhenomeX Inc. ( CELL ) Book Value ($MM) as of last quarter is 111
PhenomeX Inc. ( CELL ) Debt/Capital as of last quarter is 119%
Other Balance Sheet Stats:
PhenomeX Inc. ( CELL ) has 30 million in cash on hand as of last quarter
PhenomeX Inc. ( CELL ) has 42 million of liabilities due within 12 months, and long term debt 73 as of last quarter
PhenomeX Inc. ( CELL ) has 99 common shares outstanding as of last quarter
PhenomeX Inc. ( CELL ) has 0 million USD of preferred stock value
Academic Scores:
PhenomeX Inc. ( CELL ) Altman Z-Score is -3.84 as of last quarter
PhenomeX Inc. ( CELL ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
PhenomeX Inc. ( CELL ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of PhenomeX Inc. ( CELL ) for the amount of $ on
11.82% of PhenomeX Inc. ( CELL ) is held by insiders, and 55.85% is held by institutions
PhenomeX Inc. ( CELL ) went public on 2020-07-17
Other PhenomeX Inc. ( CELL ) financial metrics:
FCF:-61.15
Unlevered Free Cash Flow:0.00
EPS:-2.03
Operating Margin:-210.19
Gross Profit Margin:42.97
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-180.61
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About PhenomeX Inc. ( CELL ) :
PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the prevention and treatment of disease. The company's platforms are used by researchers worldwide, including pharmaceutical companies and comprehensive cancer centers. PhenomeX Inc. is headquartered in Emeryville, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.